Track the companies that matter to you. It's FREE! Click one of these fan favorites to get started: Apple; Google; Ford.



Novartis Reports Q4, 2012 Results, FDA Approval for Exjade

Watch stocks you care about

The single, easiest way to keep track of all the stocks that matter...

Your own personalized stock watchlist!

It's a 100% FREE Motley Fool service...

Click Here Now

In its Q4 and 2012 results today, Novartis (NYSE: NVS  ) announced that net sales grew 2% year-over-year on a constant currency basis to $14.8 billion during the quarter, while net income advanced 5% to $3.1 billion ($1.27 per share). For the full year, those numbers were slightly down from 2011 at $56.6 billion and 12.8 billion ($5.25), respectively.

The company also said it has received FDA approval for its Exjade. The drug treats certain patients afflicted with chronic iron overload by removing excess iron in the body, a condition that can arise from a series of blood transfusions. The FDA's nod comes on the heels of a similar approval from the European Commission.

Novartis also announced that Chairman Daniel Vasella is to leave the company in February. He had worked at Novartis for 25 years.

Read/Post Comments (0) | Recommend This Article (1)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Compare Brokers

Fool Disclosure

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 2211985, ~/Articles/ArticleHandler.aspx, 9/30/2016 2:34:40 PM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Today's Market

updated Moments ago Sponsored by:
DOW 18,334.76 191.31 1.05%
S&P 500 2,171.84 20.71 0.96%
NASD 5,318.93 49.77 0.94%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

9/30/2016 2:18 PM
NVS $79.04 Down -0.21 -0.26%
Novartis CAPS Rating: ****